Showing results (71-80 of 119) with videos related to
Sort By:
Pageof 12
European Urology Focus|July 21, 2017
Low T-cell Receptor Diversity, High Somatic Mutation Burden, and High Neoantigen Load as Predictors of Clinical Outcome in Muscle-invasive Bladder CancerNoura J Choudhury, Kazuma Kiyotani, Kai Lee Yap, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2024
One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor EradicationSteven P Wolf, Vasiliki Anastasopoulou, Kimberley Drousch, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2015
Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point MutationMatthias Leisegang, Boris Engels, Karin Schreiber, et al.Frontiers in Immunology|June 25, 2026
Profiling immunogenic neoantigen peptides elicited by personalized neoantigen vaccine in cancer patientsPeng Zhao, Clara Effenberger, Saki Matsumoto, et al.Neoplasia (New York, N.Y.)|September 11, 2022
Druggable gene alterations in Japanese patients with rare malignancyAkihiro Ohmoto, Naomi Hayashi, Ippei Fukada, et al.Clinical Chemistry|June 23, 2009
CYP2D6 genotyping for functional-gene dosage analysis by allele copy number detectionNaoya Hosono, Mamoru Kato, Kazuma Kiyotani, et al.Pharmacogenetics and Genomics|February 2, 2012
A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapyKazuma Kiyotani, Satoko Uno, Taisei Mushiroda, et al.Cancers|January 8, 2025
Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast CancerTakafumi Morisaki, Makoto Kubo, Shinji Morisaki, et al.Endocrine-Related Cancer|December 25, 2015
Germline PARP4 mutations in patients with primary thyroid and breast cancersYuji Ikeda, Kazuma Kiyotani, Poh Yin Yew, et al.Oncotarget|March 16, 2018
Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cellsTaigo Kato, Tatsuo Matsuda, Yuji Ikeda, et al.Pageof 12